2021
DOI: 10.1016/j.actbio.2021.03.058
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances and directions in the development of bioresorbable metallic cardiovascular stents: Insights from recent human and in vivo studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
38
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 74 publications
(48 citation statements)
references
References 160 publications
(243 reference statements)
0
38
0
Order By: Relevance
“…Since a biodegradable cardiovascular stent service lifetime is approximately 2 years [ 45 ], the persistent kidney exposure to Mo degradation products could lead to negative renal effects. A morphometric analysis of capsule and glomerulus can be used to assess kidney function and disease [ [55] , [56] , [57] , [58] ].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Since a biodegradable cardiovascular stent service lifetime is approximately 2 years [ 45 ], the persistent kidney exposure to Mo degradation products could lead to negative renal effects. A morphometric analysis of capsule and glomerulus can be used to assess kidney function and disease [ [55] , [56] , [57] , [58] ].…”
Section: Resultsmentioning
confidence: 99%
“…8 ). The lack of vascular inflammation at long term implantations of Mo is striking when juxtaposed to the well-known chronic inflammatory responses of Zn and Fe-based degradable materials [ 45 , 64 , 65 ].
Fig.
…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The density of mineral deposits and metal implants significantly differs from that of the bulk tissue and, hence, tissue integrity is heavily disrupted through the conventional sectioning procedure. Yet, a proper investigation of atherosclerotic plaques, dysfunctional heart valves, and failed bioprosthetic heart valves all frequently undergoing pathological mineralisation ultimately requires retained tissue architecture and the biocompatibility testing of the metal alloys for stent manufacturing ( 5 , 6 ).…”
Section: Introductionmentioning
confidence: 99%
“…Biodegradable metallic biomaterials have important research value and application prospects [ 1–5 ] ; thus, Zn‐based materials have received increased attention in the past decade. [ 6–8 ] Zn, as an essential microelement to humans (Figure 1), plays a key role in numerous biological functions [ 9 ] and offers no toxicity. [ 10 ] It appears to be one of the few physiologically acceptable metals for application in biological materials.…”
Section: Introductionmentioning
confidence: 99%